Hackensack Meridian Health
Clinical trials sponsored by Hackensack Meridian Health, explained in plain language.
-
New drug cocktail shows promise for Hard-to-Treat myeloma
Disease control OngoingThis study tested a combination of four drugs (carfilzomib, lenalidomide, vorinostat, and dexamethasone) in 17 people with multiple myeloma that had come back or stopped responding to prior treatments. The main goal was to find a safe dose and see if the combination helps control…
Phase: PHASE1, PHASE2 • Sponsor: Hackensack Meridian Health • Aim: Disease control
Last updated May 01, 2026 15:59 UTC
-
Home visitors to test mental health support for new parents
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at whether a proven mental health program can be successfully added to existing home visiting services for pregnant people and new parents in Iowa and Indiana. About 1,750 home visitors and program recipients will take part. The goal is to see how well the progra…
Phase: NA • Sponsor: Hackensack Meridian Health • Aim: Knowledge-focused
Last updated Apr 30, 2026 15:48 UTC
-
Tiny vessel test may predict leg amputation risk after artery procedure
Knowledge-focused TerminatedThis study aimed to see if a new way to measure blood flow in the smallest blood vessels could predict whether a leg can be saved after artery treatment in people with severe peripheral artery disease. The study was withdrawn before enrolling any participants, so no results are a…
Phase: NA • Sponsor: Hackensack Meridian Health • Aim: Knowledge-focused
Last updated Apr 29, 2026 15:01 UTC